UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities and Exchange Act of 1934
Date of Report (or Date of Earliest Event Reported): April 13, 2005
Tutogen Medical, Inc.
| Florida | 000-16128 | 59-3100165 | ||
| (State or Other Jurisdiction | (Commission File Number) | (I.R.S. Employer Identification | ||
| of Incorporation or Organization) | Number) |
1130 McBride Avenue, 3rd
Floor
West Paterson, NJ 07424
(Address of Principal Executive Offices)
(973) 785-0004
(Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
| Item 5.02- Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers | ||||||||
Section 5- Corporate Governance and Management
Item 5.02- Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
On April 13, 2005, Mr. Richard May tendered his resignation as a director of the Company citing that his resignation "is not related to any disagreements with the Company, the other directors or management."
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| TUTOGEN MEDICAL, INC. | ||||||
| BY: | /s/ George Lombardi | |||||
| Name: | George Lombardi | |||
| Title: | Chief Financial Officer |
Dated: April 15, 2005